Session 5 Flashcards

1
Q

Describe the regulation of body fluid osmolarity

A

[*] Body fluid osmolality is maintained by a process of osmoregulation at about 275-295 mOsm/kg. NB: at 37 degrees C, osmolality (osmoles / kg) and osmolarity (osmoles/L) are virtually identical.

[*] The hormonal regulation of plasma osmolarity occurs in the late distal tubule and collecting duct of the nephron.

[*] Disorders of water balance manifest as changes in body fluid osmolarity.

[*] Symptoms reflect changes in plasma osmolarity.

[*] The major cation of the ECF is sodium, thus changes in sodium ion concentration occur. This is not a problem with sodium balance; changes in sodium balance affect plasma volume but is a problem with osmolarity due to changes in water balance. WATER BALANCE REGULATES OSMOLARITY; SODIUM BALANCE REGULATES PLASMA VOLUME

[*] If water intake < water excretion = Plasma osmolarity increases

[*] If water intake > water excretion = Plasma osmolarity decreases

[*] If plasma osmolarity decreases renal water excretion increases (i.e. there is more water in ECF and leads to water being lost).

[*] If plasma osmolarity increases renal water excretion decreases (i.e. there is less water in ECF and water is conserved).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the variation in urinary output

A

[*] Body must match ingestion to excretion: most people on average urinate 1-1.5L/day and ingest 600-1000mOsm/day.

[*] Urinary osmolarity therefore ~500-700 mOsm/L but dependent on amount of salt in diet.

  • It could be excreted as 100mOsm/L in 10 L
  • OR 1000mOsm/L in 1L
  • Typically urine output varies between 50-1200mOsm?L

[*] Changes in plasma osmolarity are corrected by altering the total amount of water (solvent) not by changes in the solute concentration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain about Osmoreceptors including their location and what do they do?

A

[*] Two different Efferent pathways: ADH and thirst

[*] Sensors (Hypothalamic Osmoreceptors) sense changes in plasma osmolality

  • Located in the Organum Vasculoum of the Laminae Terminalis (OVLT) of the hypothalamus
  • OVLT is anterior and ventral to the third ventricle
  • The Osmoreceptors are cells that have fenestrated leaky endothelium so the cells are directly exposed to the systemic circulation.
  • They send 2nd degree signal responses which are mediated via two pathways leading to 2 different complimentary outcomes

Concentration of urine
Thirst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the thirst mechanism

A

[*] The sensation of thirst represents an extremely powerfully homeostatic protective mechanism ensuring that, providing water is available, dehydration is rapidly corrected by water intake.

  • Although the sensation of thirst is usually perceived peripherally as in drying of the oral mucosa (dry mouth), the “drinking-centre” is in the lateral pre-optic area of the hypothalamus and it is this that regulates thirst. This drinking centre is response to raised plasma osmotic pressure and reduced ECF volume.
  • The thirst mechanism is set so that it is active only when the level of hyperosmotic dehydration begins to surpass the protective capacity of the kidney (change is >10%). If the thirst mechanism is working normally, and access to water is unrestricted, renal conservation of water is not essential for efficient osmoregulation of body fluids.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the ADH mechanism

A

[*] ADH or vasopressin is a small peptide only 9 amino acids long. It acts in the late distal tubule and collecting duct to allow water reabsorption and regulate the osmolarity of plasma.

  • ADH is synthesised in the hypothalamus and stored in the posterior pituitary gland. Under conditions of predominant loss of water osmoreceptors in hypothalamus initiate release of ADH.
  • Increase in osmolarity (i.e. loss of water) stimulates ADH (1% change)
  • Decreased osmolarity inhibits ADH secretion
  • This is done via the insertion of an Aquaporin channel into the tubule wall.
  • Water filtered in the glomerulus and contained in the glomerular filtrate is then able to pass out of the tubule through the aquaporin channel back into the plasma
  • If plasma ADH levels are low, then there is little water reabsorbed in the late distal tubule or collecting duct. A large volume of dilute urine is produced (water diuresis). If plasma ADH levels are high, a small volume of concentrated urine is produced (anti-diuresis).
  • ADH also increases the permeability of the tubules to urea. Urea is an effective osmole and helps with the process that allows the kidney to produce concentrated urine.

[*] Effectors form negative feedback loops that begin within the anterior hypothalamus.

  • Increased Osmolarity stimulates osmoreceptors.
  • Secretion of ADH to decrease renal water excretion
  • Result: feedback loop which stabilizes osmolarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe drinking behaviour

A

Drinking is induced by increases in plasma osmolarity or by decreases in ECF volume

  • Thirst which, if fulfilled, increases intake of free water.
  • Stop when sufficient fluid has been consumed. Our body is able to recognise water is coming in even though GI tract absorption hasn’t occurred and water water hasn’t reached the circulation yet (osmolarity hasn’t been corrected yet) – the metering mechanisms are unknown though.

Salt Appetite:

  • Salt ingestion is the analogue of thirst – we have a hedonistic appetite (desire to eat salt which is opposite to thirst – eating for pleasure rather than need)
  • Regulatory appetite (deficiency drives need)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe ADH effect on different regions of the nephron

A

[*] ADH has no effect on the descending loop of Henle as it has squamous epithelium with loose junctions so is already permeable to water.

[*] In the PCT, 65% of the water is reabsorbed (along with 67% of Na+ accompanied by Cl- reabsorption – isomotic)

[*] In the Loop of Henle, lots of salts have been reabsorbed but volume hasn’t really changed (ascending loop of Henle is known as diluting segment)

[*] In the Cortical Collecting Duct, a tiny amount of background ADH which is always present causes a little bit of water reabsorption and maximum ADH causes slightly more water reabsorption

[*] In the medullary collecting duct, >99% of water ends up being reabsorbed if maximal ADH secretion. The amount of ADH secreted is proportional to change in plasma osmolarity. Urine is extremely concentrated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the osmolarity of tubular flow along the nephron

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain about Osmolarity vs Haemodynamic pressures

A
  • Changes in blood volume and pressure have an effect on the response to changes in osmolarity.
  • A decrease in extracellular volume causes set point of ADH secretion to lower osomlarity values and the slope of the relationship is steeper
  • When faced with circulatory collapse, the kidneys continue to conserve H20 even though this will reduce osmolarity of body fluids (the body chooses to maintain volume and pressure over osmolarity).
  • When there is an increase in plasma pressure, the opposite occurs. The set point of ADH secretion is shifted higher and slope decreases. We are prepared to accept an increase in osmolarity rather than an increase in pressure.
  • Volume is more important than osmolarity if volume crashes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the water permeability of the collecting ducts and tubules

A

[*] Apical membranes do not contain water channels (Aquaporin 2) in the absence of ADH.

[*] When ADH is released, the apical membrane has Aquaporin 2 channels rapidly inserted into it (via a cascade of protein kinase A signalling) and becomes water permeable

[*] Turnover of Aquaporin 2 is < 18 minutes

[*] With the removal of ADH, the aquaporin 2 channel is retrieved from the apical membrane by endocytosis

[*] The basolateral membrane always contains Aquaporin 3 and 4 so is always permeable to water.

[*] Any water which enters across the apical membrane is thus able to pass into the peritubular blood – resulting in a net absorption of water.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the corticopapillary osmotic gradient

A

[*] Juxtamedullary nephrons make 20-30% of total nephrons and are responsible for the development of the osmotic gradients in the renal medulla, which are used to concentrate urine.

[*] Isosmotic at cortico-medullary border. Then as you go deeper into the renal parenchyma, the osmolarity gradient increases until the medullary interstitium (gap between cells) is hyperosmotic up to 1000mosmole/L at papilla.

[*] Essential mechanism

  • Active NaCl transport in thick ascending limb
  • Recycling of urea (this is why greater change occurs in the medullary collecting duct compared to the cortical collecting duct as this where urea can be reabsorbed – through the aquaporin channels alongside water if ADH is present)
  • Unusual arrangement of blood vessels in medulla descending components in close opposition to ascending components (flow of blood in vasa recta is in opposite direction to flow of fluid in the tubule)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is the medullary gradient generated? And what is meant by Urea Recycling?

A

[*] To generate the medullary gradient, the thick ascending limb of the loop of Henle is crucial – diluting action on the filtrate:

  • Removes solute without water and therefore increases osmolarity of the interstitium (filtrate in the tubule is now hyposmotic)
  • Block NaK2Cl (NaKCC) transporters with a loop diuretic and the medullary interstitium becomes isosmotic and copious dilute urine is produced.

[*] Recycling of Urea:

  • In the medullary CD, Urea moves into the intersitium down the concentration gradient and depending on the concentration gradient, may diffuse back into the loop (cycle of movement)
  • Under the influence of ADH, fractional excretion of urea decreases and urea re-cycling increases
  • The ascending limb is impermeable to H20 but it is permeable to NaCl and Urea. As Urea is high in interstitium and low tubular fluid, it moves in passive (no ATP) processes – down concentration gradient.
  • Urea then passes back into the collecting duct where it is reabsorbed in the medullary position and more water follows. Urea is therefore recycled.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain about Counter Current Multiplication

A
  • The tubule is initially filled with isotonic fluid
  • Na+ is pumped out of the ascending loop, raising the osmotic pressure outside and lowering it inside. This creates the gradient. The maximum gradient (inside to out) is 200 mosm/L
  • Round 1: Water flows out of the descending tubule by osmosis, raising the osmotic pressure in the descending tubule to 400 mOsm/L. Fresh fluid enters from the glomerulus, pushing concentrated fluid (400 mOsm/L) into the ascending limb.
  • Round 2: the Na+ pump produces another 200 mOsm/L gradient across the membrane, but it is starting from a more concentrated solution so the external (interstitial) osmolarity rises to 500mOsm/L
  • Round 3: the third round of Na+ pumping raises interstitial concentration to 700mOsm/L (in the deepest part of the medullary interstitium) and so on.
  • The pumping, osmotic flow and filtration flows occur together as a continuous process. The final gradient will be limited by diffusional processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What maintains the corticopapillary concentration gradient?

A

[*] Concentration gradient is produced by the loop of Henle acting as a counter current multiplier BUT it is maintained by the vasa recta, acting as a counter-current exchanger (taking water away, preventing water from washing out the concentration gradient).

  • Because the flow in vasa recta is in opposite direction to fluid flow in the tubule, the osmotic gradient is maintained.
  • Blood flow in renal cortex is high – is one of the highest per gram of any tissue in the body. Descending blood runs alongside the ascending fluid in the tubule of the ascending limb of Loop of Henle.
  • Blood flow through renal medulla is low (5-10% of total Renal Plasma Flow)
  • Compromise: need to delivery nutrients and need to maintain medullary hyper-tonicity
  • Kidney uses a hair-pin configuration for vasa recta with entry and exit through the same region of the kidney, thus creating a counter current exchange mechanism.
  • The descending limb of Loop of Henle has a very concentrated filtrate and blood is also very concentrated at this point so it is in a perfect position to reabsorb water therefore water is not available to wash out concentration gradient.
  • Vasa recta has no capacity for active transport.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe what happens in the limbs of the vasa recta

A

Start with osmotic stratification in medullary interstitium (everything is driven by concentration gradients) due to presence of ADH

  • Counter current multiplier gives NaCl gradient that moves salt into the interstitium.
  • Also cortex to papilla gradient of urea
  • In presence of ADH

Descending limb of vasa recta:

  • Isosmotic blood in vasa recta enters hyperosmotic milieu of the medulla (high concentration Na+ ions, Cl- ions + urea)
  • Na+, Cl- + urea diffuse into the lumen of vasa recta
  • Osmolarity of blood in vasa recta increases as it reaches tip – bottom – of hairpin loop

Ascending limb of vasa recta:

  • Blood ascending towards cortex will have higher solute content than surrounding intersititum
  • Water moves in from the descending limb of the Loop of Henle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Consider an alternative explanation of how the vasa recta acts like a counter-current exchange? (LUSUMA NOTES)

A
  • The concentration gradient that the loop of Henle sets up would not last long though without the Vasa Recta.
  • These are blood vessels that run alongside the loops, but with opposite flow direction. This counter-current flow allows for the maintenance of the concentration gradient.
  • Isosmotic blood in the descending limb of the vasa recta enters the hyperosmotic milieu of the medulla, where there is a high concentration of ions (Na+, Cl-, Urea). These ions therefore diffuse into the vasa recta and water diffuses out.
  • The osmolarity of the blood in the vasa recta increases as it reaches the tip of the hairpin loop, where it is isosmotic with the medullary Intersticium.
  • Blood ascending towards the cortex will have a higher solute content than the surrounding Intersticium, so solutes move back out. Water will also move back in from the descending limb of the loop of Henle.
  • Therefore, although there is a large amount of fluid and solute exchange across the vasa recta, there is little net dilution of the concentration of the interstitial fluid because of the U shape of the vasa recta allowing it to act as a counter current exchanger.
  • The vasa recta therefore do not create the medullary hyperosmolarity, but do prevent it from being dissipated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Consider the role of ADH in the production of hypo- and hyperosmotic urine

A

[*] Hypo-osmotic urine

  • Reabsorb solute from nephron
  • No ADH stimulation means no Aquaporin in the latter DCT and Collecting Ducts
  • Limited water reuptake in latter DCT, and limited in collecting duct
  • Tubular fluid rich in water passes through the hyperosmotic renal pyramid with no change in water content
  • Loss of large amount of dilute urine
  • Diuresis

[*] If plasma osmolarity increases, body needs to produce a hyperosmotic urine to lower osmolarity of plasma.

  • The kidney must reabsorb as much water as possible from the kidney tubule
  • Needs a hypertonic interstitium (which eventually returns to peritubular capillaries => circulation), creating a concentration gradient so water can move out of the tubule into the interstitium passively.
18
Q

Describe the two most common problems of ADH secretion

A

[*] Diabetes insipidus: results when the pituitary gland does not produce enough ADH or from an acquired insensitivity of the kidney to ADH

  • Water is inadequately reabsorbed from the collecting ducts, so a large quantity of urine is produced
  • Diabetes insipidus often can be managed clinically by ADH injections or by ADH nasal spray treatments

[*] Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): characterized by excessive (inappropriate) release of ADH from the posterior pituitary gland or another source, when plasma osmolarity and volume is normal

  • Dilutional hyponatremia in which the plasma sodium levels are lowered and total body fluid is increased
  • Symptoms of hyponatremia include nausea and vomiting, headache, confusion, lethargy, fatigue, appetite loss, restlessness and irritability, muscle weakness, spasms, cramps, seizures and decreased consciousness or coma.
  • The condition may be treated by ADH receptor antagonists
19
Q

Describe the storage and importance of calcium in the body

A

[*] Almost all of the body calcium is stored in body (~99%) which acts as a source of calcium to replace the ion in situatons of low ECF [Ca2+]

Total calcium 25-35 mol

Calcium is involved in many important physiological processes including bone formation (see TOB) cell division and growth (see Metabolism) Calcium plays a critical role in many cellular processes:

  • Hormone secretion
  • Nerve conduction
  • Inactivation/activation of enzymes
  • Muscle contraction
  • Exocytosis

[*] Homeostasis of calcium and phosphate depend on 2 factors:

  • Total amount of ion in the body (Ca2+ and PO4^3-) which are both absorbed by the GI tract and excreted by the kidney
20
Q

Describe the percentage of unbound, free calcium ions in the blood

A

[*] Unbound free calcium ions account for 50% of the total body calcium concentration and are freely filtered at the glomerulus. The remaining 45% of the total body calcium concentration is protein bound (80% to albumin) and 5% is complexed to anions e.g. HCO3- and citrate and PO4^3-.

  • Plasma pH influences this distribution by altering protein binding to Ca2+
  • Free Ca2+ reference range: 1.1-1.3 mmol/L
  • Total adjusted calcium reference range: 2.20-2.60 mmol/L
  • NB: free calcium cannot be measured easily due to lactate accumulation in test tube sample (anaerobic respiration occurs) which changes free [Ca2+] therefore total adjusted calcium reference range is calculated.
21
Q

What goes in terms of Vit D in the intestines and kidney?

A

[*] Intestine

  • Absorption of Vitamin D is under 1,25-(OH)2D control (physiologically active form of Vitamin D)
  • 20-40% of dietary calcium (25mmol) absorbed
  • Absorption increases in growing children, pregnancy, lactation and decreases with advancing age.
  • 2-5mmolsecreted back into gut.
  • Complexing calcium, e.g. with phytates (chapattis etc), oxalates reduces absorption

[*] Kidney

Filters 250 mmol calcium per day
95-98% reabsorbed

  • 65% reabsorbed in proximal tubule (associated with sodium and water intake)
  • 20-25% recovered in ascending loop of Henle
  • 10% recovered in distal convoluted tubule under parathyroid hormone (PTH). PTH senses free Ca+ in blood on a minute to minute basis with a half life 3-5 minutes.
  • Over 24 hours, urinary calcium excretion < 10mmol. High calcium excretion can lead to renal stones.
22
Q

Describe the sources and metabolism of Vitamin D

A
  • The form of Vitamin D present in sunlight is Cholecalciferol (D3)
  • The form of Vitamin D present in oily fish, eggs and cereals is Ergocalciferol (D2)
  • 25-hydroxyase converts D3 and D2 into 25-(OH) Vitamin D (Calciferol) in the liver
  • Then in the kidney, 1 alpha-hydroxylase (PTH stimulated) converts 25-(OH) Vitamin D into 1,25-(OH)2 Vitamin D ( active form, aka calcitriol)
  • When levels of 1,25-(OH)2 Vitamin D have reached sufficient levels, the body starts converting 25-(OH) Vitamin D into 24,2-(OH)2 Vitamin D which is inert. This prevents Vitamin D toxicity
23
Q

What are the Vitamin D daily requirements and reference ranges?

A

[*] Vitamin D Daily Requirements:

200 – 400 International Units (IUs) – infants

  • 400 – 800 IU – children
  • 800 – 1000 IU in adults
  • NB: breastmilk is very poor in Vitamin D (only 15-50 IU per litre)

[*] 25-OH Vitamin D reference ranges

  • Severe deficiency <15nmol/L (treat with D2/D3 supplements)
  • Deficiency 15-30mmol/L (treat with Vit D supplements)
  • Insufficiency 30-50nmol/L (supplements only necessary if patient is symptomatic)
  • Adequate >50nmol/L
24
Q

What are risk factors for Vitamin D deficiency?

A
  • Pigmented skin (non-white ethnicity)
  • Lack of sunlight exposure or atmospheric pollution
  • Skin concealing garments or strict sunscreen use
  • Exclusively breast fed
  • Multiple, short interval pregnancies
  • Elderly, obese or institutionalized
  • Vegetarian (or other non-fish eating) diet
  • Malabsorption, short bowel, or cholestatic liver disease
  • Use of anticonvulsants, rifampicin cholestyramine, highly active antiretroviral treatment (HAART) or glucocorticoids (these increase breakdown of Vitamin D so need to give Vit D supplements)
25
Q

How does PTH regulate the formation of calcitriol?

A

[*] The formation and regulation of 1,25-(OH)2D and PTH

  • PTH increases the production of 1,25-(OH)2D (Calcitriol) which when has reached a certain level, leads to the formation of inert 24,25-(OH)2D which inhibits the parathyroid glands from releasing PTH.
  • 1,25-(OH)2D also acts on the parathyroid glands – negative feedback loop
  • 1,25-(OH)2D increases the concentration of plasma Ca2+
26
Q

What is the action of Calcitriol?

A

On bone:

  • Increases the availability of calcium and phosphate via intestinal uptake (binds to Calcium to increase gut reabsorption)
  • Promotes osteoblast activity and maturation of osteoclasts precursor cells

On kidney

  • Inhibition of renal 1 alpha-hydroxylase by intestinal absorbed phosphate
  • Promotes synthesis of 24,25-(OH)2D
  • Small effect on renal calcium and phosphate reabsorption

Other actions: regulates the functions of a wide variety of cells and tissues:

  • Cell differentiation and proliferation
  • May decrease proliferative activity of some tumour cells
  • Inhibition of cellular growth
  • Stimulation of insulin secretion
  • Modulation of immune and haemopoietic systems
  • Inhibitor of renin production

Status of Evidence of Vit D deficiency of Chronic Diseases

27
Q

What is the action of PTH?

A
  • Aids bone remodelling by stimulating osteoclast activity, increasing plasma calcium and phosphate concentration
  • Slowly stimulates osteoblast activity

Action on Kidney:

  • Increases calcium and magnesium reabsorption
  • Decreases phosphate and bicarbonate reabsorption (if they are present in the blood, calcium stones will form)
  • Stimulates conversion of 25-OHD to 1,25-(OH)2D by 1 alpha-hydroxylase
  • Bisphosphates inhibit osteoclast activity

Calcium levels are regulated by PTH

28
Q

What are the factors involved in regulating bone growth and turnover?

A
  • Calcium, phosphate and magnesium metabolism
  • PTH and calcitriol (1,25-(OH)2D)
  • Other hormones and factors such as thyroid hormones, oestrogens, androgens, cortisol, insulin, GH, IGFS, TGFBeta, FGF, PDGF, FGF23 etc
29
Q

Can PTH regulate the renal threshold?

A

[*] The renal threshold is the plasma concentration of a substance at which the transport maximum ™ is reached and the substance first starts to appear in the urine.

[*] The renal threshold for inorganic ions of PO4^3- and Ca2+ is equal to their normal plasma concentrations, which means that the maximal reabsorption of these ions via transporter carriers in the renal tubule is equivalent to their normal plasma concentrations.

[*] PTH can adjust the renal threshold

30
Q

What are the main causes of hypercalcaemia?

A
  • Primary hyperparathyroidism: about 1:1000 of the general population. Normally 1 gland, occasionally 2 of the parathyroid glands are affected – adenoma causes them to become autonomous and produce PTH without any feedback mechanism
  • Haematological malignancies
  • Non-haematological malignancies
  • Others
31
Q

What is the clinical manifestation of hypercalcaemia?

A

Quite non-specific

Gastrointestinal

  • Anorexia
  • Nausea/vomiting
  • Constipation
  • Rarely acute pancreatitis

Cardiovascular

  • Hypertension
  • Shortened QT interval on ECG
  • Enhanced sensitivity to digoxin

Renal

  • Polyuria and polydipsia
  • Occasional nephrocalcinosis

Central Nervous System

  • Cognitive difficulties and apthy
  • Depression
  • Drowsiness, coma

NB: if total adjusted calcium reference range is >3.5mmol/L, this is a medical emergency that requires hospital treatment. And in Primary hyperparathyroidism, plasma intact PTH is the diagnosis of choice (raised)

32
Q

Compare hyperparathyroidism and hypercalcaemia due to malignancy

A

In primary hyperparathyroidism:

  • Raised: plasma calcium, PTH, urinary cAMP, plasma calcitriol, bone resorption, bone formation
  • Suppressed: plasma phosphate

Humoral Hypercalcaemia of malignancy:

  • Raised: plasma calcium, urinary cAMP, bone resorption
  • Suppressed: plasma phosphate, PTH, plasma calcitriol, bone formation
33
Q

Describe plasma calcium levels in different types of hyperparathyroidism

A
  • Primary hyperparathyroidism: raised plasma calcium
  • Secondary hyperparathyroidism: low or normal plasma calcium
  • Tertiary hyperparathyroidism: raised plasma calcium (patient had kidney failure and normally all 4 parathyroid glands developed adenomas and became autonomous. After a kidney transplant, the parathyroid glands remained autonomous. Progression through secondary hyperparathyroidism)
34
Q

What factors are present in hypercalcaemia due to malignancy?

A

Parathyroidhormone-related peptides (PTHrP), secreted by malignancies

  • Amino acid homology with N-terminal of PTH (active portion of PTH) so some similar actions
  • Laboratory tests do not cross over

Other factors present in malignancy are also thought to contribute to hypercalcaemia

  • Cytokines e.g. Tumour necrosis factor, IL-1
  • Transforming growth factor alpha
  • Prostaglandins
35
Q

Describe management of acute hypercalcaemia (generally)

A

General measures:

  • Hydration
  • Loop diuretics e.g. frusemide (NOT thiazides which cause increased Ca2+ reabsorption). Ensure cardiovascular function is able to deal with extra volume in plasma.

Specific measures:

  • Bisphosphonates (inhibit osteoclast activity)
  • Calcitonin
  • Glucocorticoids

Treat underlying condition

36
Q

Describe the risk and symptoms of renal stone formation

A
  1. Approximately 20% men and 5-10% women will develop renal stones (sudden severe pain)
  2. 50% recurrence rate within 5 years from first stone
  3. After 8 years 63% men and 18% women form additional stones
  4. Racial differences in stone formation

[*] Manifestation of renal stones

  • Not necessarily symptomatic – incidental finding on abdominal imaging (e.g. x-rays)
  • Haematuria (blood in urine)
  • Pain and associated complications of an obstruction in the renal tract
  • Likely to be stone if pain and haematuria
  • Likely to be malignancy if haematuria and no pain
37
Q

What are different types of calcium stones? And what factors contribute to their formation

A

[*] Calcium stones are the most common (70-80%)

[*] Factors involved in renal stone formation:

  • Low urine volume
  • Hypercalcuria which could absorptive (increased absorption due to an abnormality in the intestines leading to increased excretion by the kidneys so plasma [Ca2+] is normal) or renal (problem in the kidneys so more Ca2+ goes into the urine – inefficient reabsorption)
  • Primary hyperparathyroidism
  • Hyperoxaluria
  • Hyperuricosuria
  • Hypocitraturia
  • Hypomagnesuria
  • Others
38
Q

Describe the mechanism of stone formation

A

[*] Mechanism of stone formation: the processes by which crystals form, grow and aggregate to form renal stones are complex

  • Urine supersaturation with respect to calcium oxalate
  • Ionic strength e.g. sodium, potassium chloride etc reduce risk of crystal formation
  • pH e.g. acidosis reduces urinary citrate by enhancing renal tubular re-absorption and reducing synthesis of citrate
  • At low urine pH (<5.47) uric acid stone formation is favoured and may promote calcium oxalate stones
39
Q

What are promoters and inhibitors of calcium oxalate and calcium phosphate stones?

A

[*] Promoters of calcium oxalate and calcium phosphate stones:

  • Organic matrix
  • Tamm-Horsfall mucoproteins

[*] Inhibitors of calcium oxalate and calcium phosphate stones:

  • Citrate
  • Pyrophosphate
  • Glycosaminoglycans
  • RNA fragments
  • Acidic glycoproteins
  • Magnesium
40
Q

How would evaluate renal stone formers?

A

History

  • Underlying predisposing conditions
  • Dietary excesses, inadequate fluid intake or excessive fluid loss
  • Medications

Blood Screen: Ca, PTH, PO4, urate, U/Es and acid base status
Urine Screen:

  • Urinalysis: pH, sediments
  • Culture: urea-splitting organisms

Radiograph (remember not all stones appear in an x-ray)

  • Radiopaque stones: calcium oxalate, calcium phosphate, struvite, cysteine
  • Radiolucent stones: urate, xanthine, 2-hydroxyadenine
  • Intravenous pyelogram (IVP)

Biochemical stone analysis

41
Q

Describe conservative medical management of renal stones

A
  • Increase fluid intake: urine output >2L daily
  • Dietary restriction of oxalate and sodium for all
  • Consider dietary restriction of: calcium and animal proteins
  • Urology referral for lithotripsy (procedure that uses shock waves to break up stones)/surgery
42
Q

What are the effects of Pharmacologic Therapy?

A
  • Sodium Cellulose Phosphate suppresses urinary calcium
  • Thiazide increases calcium reabsorption in kidney leading to less Ca2+ excretion
  • Allopurinol inhibits xanthine oxidase => inhibits urinary uric acid formation
  • Potassium Citrate increases urinary citrate (hypocitraturia is an important risk factor for kidney stone formation